Skip to search formSkip to main contentSkip to account menu

AMYOTROPHIC LATERAL SCLEROSIS 1

Known as: ALS1, Amyotrophic Lateral Sclerosis, Familial, AMYOTROPHIC LATERAL SCLEROSIS 1, FAMILIAL 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Genome editing and gene insertion in maize is advanced with Cas9-guide RNA technology. Targeted mutagenesis, editing of… 
Highly Cited
2012
Highly Cited
2012
Participatory Action Research (PAR) is a qualitative research methodology option that requires further understanding and… 
Highly Cited
2010
Highly Cited
2010
Amyotrophic lateral sclerosis (ALS) has its onset in middle age and is a progressive disorder characterized by degeneration of… 
Highly Cited
2010
Highly Cited
2010
Amyotrophic lateral sclerosis (ALS) is a fatal disorder of motor neuron degeneration. Most cases of ALS are sporadic (SALS), but… 
Highly Cited
2008
Highly Cited
2008
There are about 100 single point mutations of copper, zinc superoxide dismutase 1 (SOD1) which are reported (http://alsod.iop.kcl… 
Highly Cited
2007
Highly Cited
2007
Amyotrophic lateral sclerosis (ALS) is a common, fatal motor neuron disorder with no effective treatment. Approximately 10% of… 
Highly Cited
2006
Highly Cited
2006
The fungal pathogen Candida albicans is frequently associated with catheter-based infections because of its ability to form… 
Review
2005
Review
2005
Copper-zinc superoxide dismutase (CuZnSOD, SOD1 protein) is an abundant copper- and zinc-containing protein that is present in… 
Highly Cited
2003
Highly Cited
2003
Cu/Zn superoxide dismutase (SOD1), a crucial cellular antioxidant, can in certain settings mediate toxic chemistry through its Cu… 
Highly Cited
1998
Highly Cited
1998
Reactive oxygen (RO) has been identified as an important effector in ageing and lifespan determination. The specific cell types…